Association between faecalibacterium prausnitzii reduction and inflammatory bowel disease: A meta-analysis and systematic review of the literature

Gastroenterology Research and Practice

Volumn 2014, Issue , 2014, Pages

  Cao, Yuan ^a   Shen, Jun ^a   Ran, Zhi Hua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EMBASE; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INFORMATION RETRIEVAL; INTESTINE FLORA; MEDLINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMATIC REVIEW;

EID: 84899536462     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2014/872725     Document Type: Article

References (41)

1. Martinez-Medina M., Aldeguer X., Gonzalez-Huix F., Acero D., Garcia-Gil L. J., Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflammatory Bowel Diseases 2006 12 12 1136 1145 2-s2.0-33751556362 10.1097/01.mib.0000235828.09305.0c
2. Jostins L., Ripke S., Weersma R. K., Duerr R. H., McGovern D. P., Hui K. Y., Lee J. C., Schumm L. P., Sharma Y., Anderson C. A., Essers J., Mitrovic M., Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012 491 7422 119 124 10.1038/nature11582
3. Chassaing B., Darfeuille-Michaud A., The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011 140 6 1720 1728 2-s2.0-79955554300 10.1053/j.gastro.2011. 01.054
4. Walker A. W., Sanderson J. D., Churcher C., Parkes G. C., Hudspith B. N., Rayment N., Brostoff J., Parkhill J., Dougan G., Petrovska L., High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiology 2011 11 article 7 2-s2.0-78650973052 10.1186/1471-2180-11-7
5. Arumugan M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D. R., Fernandes G. R., Tap J., Bruls T., Batto J. -M., Bertalan M., Borruel N., Casellas F., Fernandez L., Enterotypes of the human gut microbioma. Nature 2011 473 7346 174 180 10.1038/nature09944
6. Louis P., Flint H. J., Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiology Letters 2009 294 1 1 8 2-s2.0-63849241608 10.1111/j.1574-6968.2009.01514.x
7. Packey C. D., Sartor R. B., Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Current Opinion in Infectious Diseases 2009 22 3 292 301 2-s2.0-65549129496 10.1097/QCO.0b013e32832a8a5d
8. Machiels K., Joossens M., Sabino J., de Preter V., Arijs I., Eeckhaut V., Ballet V., Claes K., Van Immerseel F., Verbeke K., Ferrante M., Verhaegen J., Rutgeerts P., Vermeire S., A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2013 10.1136/gutjnl-2013-304833
9. Dörffel Y., Swidsinski A., Loening-Baucke V., Wiedenmann B., Pavel M., Common biostructure of the colonic microbiota in neuroendocrine tumors and Crohn's disease and the effect of therapy. Inflammatory Bowel Diseases 2012 18 9 1663 1671 2-s2.0-81555235930 10.1002/ibd.21923
10. Machiels K., Joossens M., de Preter V., Arijs I., Ballet V., Organe S., Coopmans T., van Assche G. A., Verhaegen J., Rutgeert P. J., Association of Faecalibacterium prausnitzii and disease activity in ulcerative colitis. Gastroenterology 2011 140 supplement 1, article S142 5 10.1016/S0016-5085(11) 60576-3
11. Luther J., Dave M., Higgins P. D. R., Kao J. Y., Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflammatory Bowel Diseases 2010 16 6 1077 1084 2-s2.0-77952692062 10.1002/ibd.21116
12. Varela E., Manichanh C., Gallart M., Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics 2013 38 2 151 161 10.1111/apt.12365
13. Swidsinski A., Loening-Baucke V., Vaneechoutte M., Doerffel Y., Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflammatory Bowel Diseases 2008 14 2 147 161 2-s2.0-39649100206 10.1002/ibd.20330
14. Vermeiren J., van den Abbeele P., Laukens D., Vigsnæs L. K., de Vos M., Boon N., van de Wiele T., Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. FEMS Microbiology Ecology 2012 79 3 685 696 2-s2.0-84856025771 10.1111/j.1574-6941.2011.01252.x
15. Joossens M., Huys G., Cnockaert M., de Preter V., Verbeke K., Rutgeerts P., Vandamme P., Vermeire S., Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011 60 5 631 637 2-s2.0-79953748870 10.1136/gut.2010.223263
16. Wang W., Chen L., Zhou R., Wang X., Song L., Huang S., Wang G., Xia B., Increased proportion of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. Journal of Clinical Microbiology 2013 10.1128/JCM.01500-13
17. Jia W., Whitehead R. N., Griffiths L., Dawson C., Waring R. H., Ramsden D. B., Hunter J. O., Cole J. A., Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiology Letters 2010 310 2 138 144 2-s2.0-77956045880 10.1111/j.1574-6968.2010.02057.x
18. Sokol H., Seksik P., Furet J. P., Firmesse O., Nion-Larmurier I., Beaugerie L., Cosnes J., Corthier G., Marteau P., Doraé J., Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflammatory Bowel Diseases 2009 15 8 1183 1189 2-s2.0-70349488325 10.1002/ibd.20903
19. Andoh A., Kuzuoka H., Tsujikawa T., Nakamura S., Hirai F., Suzuki Y., Matsui T., Fujiyama Y., Matsumoto T., Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease. Journal of Gastroenterology 2012 47 12 1298 1307 10.1007/s00535-012-0605-0
20. Willing B., Halfvarson J., Dicksved J., Rosenquist M., Järnerot G., Engstrand L., Tysk C., Jansson J. K., Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflammatory Bowel Diseases 2009 15 5 653 660 2-s2.0-66249129571 10.1002/ibd.20783
21. Fujimoto T., Imaeda H., Takahashi K., Kasumi E., Bamba S., Fujiyama Y., Andoh A., Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. Journal of Gastroenterology and Hepatology 2013 28 4 613 619 10.1111/jgh.12073
22. Galecka M., Szachta P., Bartnicka A., Łykowska-Szuber L., Eder P., Schwiertz A., Faecalibacterium prausnitzii and Crohn's disease-is there any connection? Polish Journal of Microbiology 2013 62 1 91 95
23. Miquel S., Marín R., Rossi O., Bermudez-Humaran L. G., Chatel J. M., Sokol H., Thomas M., Wells J. M., Langella P., Faecalibacterium prausnitzii and human intestinal health. Current Opinion in Microbiology 2013 16 3 255 261 10.1016/j.mib.2013.06.003
24. Hansen R., Russell R. K., Reiff C., Louis P., McIntosh F., Berry S. H., Mukhopadhya I., Bisset W. M., Barclay A. R., Bishop J., Loganathan S., Mahdi G., Flint H. J., El-Omar E. M., Hold G. L., Microbiota of Pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. The American Journal of Gastroenterology 2012 107 12 1913 1922 10.1038/ajg.2012.335
25. O'Brien C. L., Allison G. E., Pavli P., The more the merrier: Faecalibacterium prausnitzii in Crohn's disease. Journal of Gastroenterology and Hepatology 2013 28 5 757 759 10.1111/jgh.12153
26. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez- Humarán L. G., Gratadoux J.-J., Blugeon S., Bridonneau C., Furet J.-P., Corthier G., Grangette C., Vasquez N., Pochart P., Trugnan G., Thomas G., Blottière H. M., Doré J., Marteau P., Seksik P., Langella P., Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences of the United States of America 2008 105 43 16731 16736 2-s2.0-55949124035 10.1073/pnas.0804812105
27. Qiu X., Zhang M., Yang X., Hong N., Yu C., Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. Journal of Crohn's and Colitis 2013 7 11 e558 e568 10.1016/j.crohns.2013.04.002
28. Wang M., Molin G., Ahrné S., Adawi D., Jeppsson B., High proportions of proinflammatory bacteria on the colonic mucosa in a young patient with ulcerative colitis as revealed by cloning and sequencing of 16S rRNA genes. Digestive Diseases and Sciences 2007 52 3 620 627 2-s2.0-33847200125 10.1007/s10620-006-9461-1
29. Mondot S., Kang S., Furet J. P., de Carcer D. A., McSweeney C., Morrison M., Marteau P., Doré J., Leclerc M., Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflammatory Bowel Diseases 2011 17 1 185 192 2-s2.0-78650155416 10.1002/ibd.21436
30. Siaw Y. H., Hart A., Commentary: is Faecalibacterium prausnitzii a potential treatment for maintaining remission in ulcerative colitis? Alimentary Pharmacology & Therapeutics 2013 38 5 551 10.1111/apt.12404
31. Maccaferri S., Vitali B., Klinder A., Kolida S., Ndagijimana M., Laghi L., Calanni F., Brigidi P., Gibson G. R., Costabile A., Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. Journal of Antimicrobial Chemotherapy 2010 65 12 2556 2565 2-s2.0-78149477874 10.1093/jac/dkq345
32. Benjamin J. L., Hedin C. R., Koutsoumpas A., Ng S. C., McCarthy N. E., Prescott N. J., Pessoa-Lopes P., Mathew C. G., Sanderson J., Hart A. L., Kamm M. A., Knight S. C., Forbes A., Stagg A. J., Lindsay J. O., Whelan K., Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflammatory Bowel Diseases 2012 18 6 1092 1100 10.1002/ibd.21864
33. Angelberger S., Reinisch W., Makristathis A., Lichtenberger C., Dejaco C., Papay P., Novacek G., Trauner M., Loy A., Berry D., Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. The American Journal of Gastroenterology 2013 108 10 1620 1630 10.1038/ajg.2013.257
34. McLaughlin S. D., Walker A. W., Churcher C., Clark S. K., Tekkis P. P., Johnson M. W., Parkhill J., Ciclitira P. J., Dougan G., Nicholls R. J., Petrovska L., The bacteriology of pouchitis: a molecular phylogenetic analysis using 16s rRNA gene cloning and sequencing. Annals of Surgery 2010 252 1 90 98 2-s2.0-77954084505 10.1097/SLA.0b013e3181e3dc8b
35. Cucchiara S., Iebba V., Conte M. P., Schippa S., The microbiota in inflammatory bowel disease in different age groups. Digestive Diseases 2009 27 3 252 258 2-s2.0-70349910595 10.1159/000228558
36. Ashelford K. E., Chuzhanova N. A., Fry J. C., Jones A. J., Weightman A. J., At least 1 in 20 16S rRNA sequence records currently held in public repositories is estimated to contain substantial anomalies. Applied and Environmental Microbiology 2005 71 12 7724 7736 2-s2.0-29144504177 10.1128/AEM.71.12.7724-7736.2005
37. Duncan S. H., Louis P., Flint H. J., Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Applied and Environmental Microbiology 2004 70 10 5810 5817 2-s2.0-8144224956 10.1128/AEM.70.10.5810-5817.2004
38. Macfarlane G. T., Macfarlane S., Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. Journal of Clinical Gastroenterology 2011 45 supplemment S120 S127 2-s2.0-80054111810 10.1097/MCG.0b013e31822fecfe
39. Himmel M. E., Yao Y., Orban P. C., Steiner T. S., Levings M. K., Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Immunology 2012 136 2 115 122 2-s2.0-84860259163 10.1111/j.1365-2567. 2012.03572.x
40. Benus R. F. J., van der Werf T. S., Welling G. W., Judd P. A., Taylor M. A., Harmsen H. J. M., Whelan K., Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. British Journal of Nutrition 2010 104 5 693 700 2-s2.0-77956914321 10.1017/S0007114510001030
41. Prideaux L., Kang S., Wagner J., Buckley M., Mahar J. E., De Cruz P., Wen Z., Chen L., Xia B., van Langenberg D. R., Lockett T., Ng S. C., Sung J. J., Desmond P., McSweeney C., Morrison M., Kirkwood C. D., Kamm M. A., Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease. Inflammatory Bowel Diseases 2013 19 13 2906 2918 10.1097/01.MIB.0000435759.05577.12